Cheryl D. Coon

607 total citations
23 papers, 414 citations indexed

About

Cheryl D. Coon is a scholar working on Oncology, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Cheryl D. Coon has authored 23 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Economics and Econometrics and 3 papers in Molecular Biology. Recurrent topics in Cheryl D. Coon's work include Cancer Immunotherapy and Biomarkers (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Economic and Financial Impacts of Cancer (5 papers). Cheryl D. Coon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Economic and Financial Impacts of Cancer (5 papers). Cheryl D. Coon collaborates with scholars based in United States, France and Germany. Cheryl D. Coon's co-authors include Karon F. Cook, Joseph C. Cappelleri, Fiona Taylor, Homa Dastani, I. Gilloteau, Caroline Robert, Kerry J. Savage, Ian M. Waxman, Piotr Rutkowski and Amy P. Abernethy and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Cheryl D. Coon

22 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl D. Coon United States	10	154	93	57	43	41	23	414
Ruchit Shah United States	14	117 0.8×	76 0.8×	108 1.9×	61 1.4×	27 0.7×	61	448
Katharine S. Gries United States	11	98 0.6×	116 1.2×	51 0.9×	35 0.8×	19 0.5×	41	618
Dominique Lejeune United States	14	106 0.7×	41 0.4×	129 2.3×	56 1.3×	31 0.8×	64	570
Mousumi Biswas United Kingdom	13	75 0.5×	36 0.4×	102 1.8×	25 0.6×	48 1.2×	33	420
Chia Jie Tan United States	13	168 1.1×	144 1.5×	174 3.1×	54 1.3×	33 0.8×	48	520
Michael W. Pill United States	9	88 0.6×	67 0.7×	44 0.8×	42 1.0×	24 0.6×	10	531
Huah Shin Ng Australia	14	162 1.1×	49 0.5×	65 1.1×	92 2.1×	18 0.4×	36	548
Evan Kantor United States	10	86 0.6×	166 1.8×	46 0.8×	69 1.6×	93 2.3×	19	796
Kathy Oliver United Kingdom	10	140 0.9×	82 0.9×	82 1.4×	31 0.7×	28 0.7×	36	478
Jonathan R. Korn United States	17	141 0.9×	81 0.9×	49 0.9×	99 2.3×	118 2.9×	37	855

Countries citing papers authored by Cheryl D. Coon

Since Specialization

Citations

This map shows the geographic impact of Cheryl D. Coon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl D. Coon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl D. Coon more than expected).

Fields of papers citing papers by Cheryl D. Coon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl D. Coon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl D. Coon. The network helps show where Cheryl D. Coon may publish in the future.

Co-authorship network of co-authors of Cheryl D. Coon

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl D. Coon. A scholar is included among the top collaborators of Cheryl D. Coon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl D. Coon. Cheryl D. Coon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coon, Cheryl D., Hien Q. Huynh, Diane Stephenson, et al.. (2025). Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem. Journal of Medical Internet Research. 27. e67052–e67052.

Trigg, Andrew, et al.. (2024). Conceptualizing meaningful between-group difference in change over time: a demonstration of possible viewpoints. Quality of Life Research. 34(1). 151–160. 3 indexed citations

Taylor, Douglas C.A., et al.. (2023). CO55 Psychometric Evaluation of the Measurement Properties of a Pediatric Clinical Outcome Assessment for Functional Constipation: Data from a Phase 3 Clinical Trial. Value in Health. 26(6). S24–S24. 1 indexed citations

Hudgens, Stacie, et al.. (2023). Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development. Value in Health. 26(8). 1242–1248. 4 indexed citations

Coon, Cheryl D., et al.. (2022). Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13. Patient. 15(6). 691–702. 16 indexed citations

Coon, Cheryl D., Jonathan Stokes, J. Jason Lundy, et al.. (2021). Development of the Presbyopia Impact and Coping Questionnaire. Ophthalmology and Therapy. 10(4). 1057–1075. 10 indexed citations

Lundy, J. Jason, et al.. (2020). Collection of Post-treatment PRO Data in Oncology Clinical Trials. Therapeutic Innovation & Regulatory Science. 55(1). 111–117. 5 indexed citations

Cook, Karon F., Michael A. Kallen, Cheryl D. Coon, David Victorson, & Deborah Miller. (2017). Idio Scale Judgment: evaluation of a new method for estimating responder thresholds. Quality of Life Research. 26(11). 2961–2971. 9 indexed citations

Coon, Cheryl D. & Karon F. Cook. (2017). Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores. Quality of Life Research. 27(1). 33–40. 92 indexed citations

10.

Xu, Jianming, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 351–351. 7 indexed citations

11.

Crawford, Bruce, Narayanan Prepageran, Bee See Goh, et al.. (2016). Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study. Drugs - Real World Outcomes. 4(1). 21–31. 16 indexed citations

12.

Long, Georgina V., Victoria Atkinson, Paolo A. Ascierto, et al.. (2016). Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study. Annals of Oncology. 27(10). 1940–1946. 89 indexed citations

13.

Shields, Alan L., Cheryl D. Coon, Yanni Hao, et al.. (2015). Patient-reported outcomes for US oncology labeling: review and discussion of score interpretation and analysis methods. Expert Review of Pharmacoeconomics & Outcomes Research. 15(6). 951–959. 14 indexed citations

14.

Reck, Martin, Cheryl D. Coon, Fiona Taylor, et al.. (2015). 460P Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017. Annals of Oncology. 26. ix125–ix125. 5 indexed citations

15.

Coon, Cheryl D. & Joseph C. Cappelleri. (2015). Interpreting Change in Scores on Patient-Reported Outcome Instruments. Therapeutic Innovation & Regulatory Science. 50(1). 22–29. 70 indexed citations

16.

Long, Georgina V., Victoria Atkinson, Paolo A. Ascierto, et al.. (2015). Effect of nivolumab (NIVO) on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): results of a phase III study (CheckMate 066). Annals of Oncology. 26. vi28–vi28. 1 indexed citations

17.

Long, Georgina V., Victoria Atkinson, Paolo A. Ascierto, et al.. (2015). Effect of nivolumab (NIVO) on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): Results of a phase III study (CheckMate 066).. Journal of Clinical Oncology. 33(15_suppl). 9027–9027. 3 indexed citations

18.

Abernethy, Amy Pickar, Michael A. Postow, Jason Chesney, et al.. (2015). Effect of nivolumab (NIVO) in combination with ipilimumab (IPI) versus IPI alone on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): Results of a phase II study (CheckMate 069).. Journal of Clinical Oncology. 33(15_suppl). 9029–9029. 7 indexed citations

19.

Reck, Martin, Cheryl D. Coon, Fiona Taylor, et al.. (2015). 3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017. European Journal of Cancer. 51. S599–S600. 11 indexed citations

20.

DeMuro, Carla, et al.. (2014). Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment. 10. 887–887. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact